Skip to main content
Premium Trial:

Request an Annual Quote

UW-Madison Selects Cartagenia's Bench Platform for Genomic Analysis

Premium

Cartagenia said this week that the University of Wisconsin-Madison has selected its Bench platform for use in its healthcare facilities including Wisconsin State Laboratory of Hygiene, the UW Biotech Center, and other institutions.

Cartagenia's Bench solution is a cloud-based software and database platform that provides tools and content that genetics labs can use to analyze, interpret, report, and share genomic variations in clinical diagnostics settings.

UW-Madison selected Cartagenia's solution after a public tender competition. CEO Herman Verrelst said in a statement that the company will work closely with the institution to install and customizing the solutions to meet the university's needs.

Financial and other terms of the deal were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.